Last reviewed · How we verify
Prognosis Value of the Neuronal Damage Detected by Positrons Emission Tomography (PET) With 11C-Flumazenil in Early Multiple Sclerosis. (Flumatep_2)
In this study the investigators will use PET and 11C-Flumazenil to visualize and quantify neuronal injury in the cortex and the deep gray matter of Multiple Sclerosis patients at an early stage. The investigators will follow up patients to determine the prognostic value of this neuronal injury.
Details
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 60 |
| Start date | 2013-06 |
| Completion | 2019-06 |
Conditions
- Multiple Sclerosis
Interventions
- PET with 11C-Flumazenil
Primary outcomes
- neuronal imaging — 2 years
Prognosis value of the neuronal imaging on 2 years evolution (atrophy and EDSS)
Countries
France